Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Distler

Showing results (11-20 of 350) with videos related to

Pageof 35
Sort By:
Geburtshilfe Und Frauenheilkunde|April 1, 1980
[Unusual findings in gynecological surgery I. Case report of a retroperitoneal myoma (author's transl)]V Schwanitz, W Distler
Zeitschrift Fur Geburtshilfe Und Perinatologie|July 1, 1983
[Critical analysis of fetal risk recognition by serum estriol determination]W Distler, J C Kiwit
Rheumatology (Oxford, England)|September 17, 2008
Intracellular tyrosine kinases as novel targets for anti-fibrotic therapy in systemic sclerosisJ H W Distler, O Distler
Rheumatology (Oxford, England)|September 17, 2008
Criteria to select molecular targets for anti-fibrotic therapyJ H W Distler, O Distler
Current Rheumatology Reports|January 8, 2013
Morphogen pathways in systemic sclerosisChristian Beyer, Jörg H W Distler
Experimental Dermatology|October 15, 2013
Canonical Wnt signalling as a key regulator of fibrogenesis - implications for targeted therapies?Clara Dees, Jörg H W Distler
Annals of the Rheumatic Diseases|December 10, 2009
Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapiesJ H W Distler, O Distler
Current Rheumatology Reviews|February 19, 2015
Promising anti-fibrotic approaches for future treatment of systemic sclerosisJorg H W Distler, Oliver Distler
Therapeutic Advances in Musculoskeletal Disease|August 15, 2022
A broad look into the future of systemic sclerosisGabriela Riemekasten, Jörg H W Distler
Deutsche Zahnarztliche Zeitschrift|May 1, 1980
[Reciprocal in vitro actions of Streptococcus mutans, Actinomyces and Veillonella: a simplified model for carbohydrate metabolism in plaque]W Distler, K Ott, A Kröncke
Pageof 35

Showing results (11-20 of 350) with videos related to

Sort By:
Pageof 35
Geburtshilfe Und Frauenheilkunde|April 1, 1980
[Unusual findings in gynecological surgery I. Case report of a retroperitoneal myoma (author's transl)]V Schwanitz, W Distler
Zeitschrift Fur Geburtshilfe Und Perinatologie|July 1, 1983
[Critical analysis of fetal risk recognition by serum estriol determination]W Distler, J C Kiwit
Rheumatology (Oxford, England)|September 17, 2008
Intracellular tyrosine kinases as novel targets for anti-fibrotic therapy in systemic sclerosisJ H W Distler, O Distler
Rheumatology (Oxford, England)|September 17, 2008
Criteria to select molecular targets for anti-fibrotic therapyJ H W Distler, O Distler
Current Rheumatology Reports|January 8, 2013
Morphogen pathways in systemic sclerosisChristian Beyer, Jörg H W Distler
Experimental Dermatology|October 15, 2013
Canonical Wnt signalling as a key regulator of fibrogenesis - implications for targeted therapies?Clara Dees, Jörg H W Distler
Annals of the Rheumatic Diseases|December 10, 2009
Tyrosine kinase inhibitors for the treatment of fibrotic diseases such as systemic sclerosis: towards molecular targeted therapiesJ H W Distler, O Distler
Current Rheumatology Reviews|February 19, 2015
Promising anti-fibrotic approaches for future treatment of systemic sclerosisJorg H W Distler, Oliver Distler
Therapeutic Advances in Musculoskeletal Disease|August 15, 2022
A broad look into the future of systemic sclerosisGabriela Riemekasten, Jörg H W Distler
Deutsche Zahnarztliche Zeitschrift|May 1, 1980
[Reciprocal in vitro actions of Streptococcus mutans, Actinomyces and Veillonella: a simplified model for carbohydrate metabolism in plaque]W Distler, K Ott, A Kröncke
Pageof 35